Cargando…
Re-Assessing PK/PD Issues for Oral Protein and Peptide Delivery
Due to a lack of safe and effective oral delivery strategies for most protein and peptide therapeutics, pharmaceutical drug developers have focused on parenteral routes to administer these agents. Recent advances in delivery technologies have now shown clinical validation for a few of these biopharm...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309183/ https://www.ncbi.nlm.nih.gov/pubmed/34371698 http://dx.doi.org/10.3390/pharmaceutics13071006 |